AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Arvin, AM
Citation: Am. Arvin, Varicella-zoster virus: molecular virology and virus-host interactions, CURR OPIN M, 4(4), 2001, pp. 442-449

Authors: Abendroth, A Arvin, AM
Citation: A. Abendroth et Am. Arvin, Immune evasion as a pathogenic mechanism of varicella zoster virus, SEMIN IMMUN, 13(1), 2001, pp. 27-39

Authors: Hata, A Zerboni, L Sommer, M Kaspar, AA Clayberger, C Krensky, AM Arvin, AM
Citation: A. Hata et al., Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells, VIRAL IMMUN, 14(2), 2001, pp. 125-133

Authors: Arvin, AM
Citation: Am. Arvin, Varicella vaccine: Genesis, efficacy, and attenuation, VIROLOGY, 284(2), 2001, pp. 153-158

Authors: Kimberlin, DW Lin, CY Jacobs, RF Powell, DA Frenkel, LM Gruber, WC Rathore, M Bradley, JS Diaz, PS Kumar, M Arvin, AM Gutierrez, K Shelton, M Weiner, LB Sleasman, JW de Sierra, TM Soong, SJ Kiell, J Lakeman, FD Whitley, RJ
Citation: Dw. Kimberlin et al., Natural history of neonatal herpes simplex virus infections in the acyclovir era, PEDIATRICS, 108(2), 2001, pp. 223-229

Authors: Kimberlin, DW Lin, CY Jacobs, RF Powell, DA Corey, L Gruber, WC Rathore, M Bradley, JS Diaz, PS Kumar, M Arvin, AM Gutierrez, K Shelton, M Weiner, LB Sleasman, JW de Sierra, TM Weller, S Soong, SJ Kiell, J Lakeman, FD Whitley, RJ
Citation: Dw. Kimberlin et al., Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections, PEDIATRICS, 108(2), 2001, pp. 230-238

Authors: Arvin, AM
Citation: Am. Arvin, Varicella vaccine - The first six years., N ENG J MED, 344(13), 2001, pp. 1007-1009

Authors: Sommer, MH Zagha, E Serrano, OK Ku, CC Zerboni, L Baiker, A Santos, R Spengler, M Lynch, J Grose, C Ruyechan, W Hay, J Arvin, AM
Citation: Mh. Sommer et al., Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus, J VIROLOGY, 75(17), 2001, pp. 8224-8239

Authors: Abendroth, A Lin, I Slobedman, B Ploegh, H Arvin, AM
Citation: A. Abendroth et al., Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells, J VIROLOGY, 75(10), 2001, pp. 4878-4888

Authors: Wang, ZH Gershon, MD Lungu, O Zhu, ZL Mallory, S Arvin, AM Gershon, AA
Citation: Zh. Wang et al., Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: Interactions ofglycoproteins with tegument, J VIROLOGY, 75(1), 2001, pp. 323-340

Authors: Gans, H Yasukawa, L Rinki, M DeHovitz, R Forghani, B Beeler, J Audet, S Maldonado, Y Arvin, AM
Citation: H. Gans et al., Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months, J INFEC DIS, 184(7), 2001, pp. 817-826

Authors: Shetty, AK Gans, HA So, S Millan, MT Arvin, AM Gutierrez, KM
Citation: Ak. Shetty et al., Intravenous ribavirin therapy for adenovirus pneumonia, PEDIAT PULM, 29(1), 2000, pp. 69-73

Authors: Arvin, AM
Citation: Am. Arvin, Varicella-zoster virus: Pathogenesis, immunity, and clinical management inhematopoietic cell transplant recipients, BIOL BLOOD, 6(3), 2000, pp. 219-230

Authors: Arvin, AM
Citation: Am. Arvin, Measles vaccines - A positive step toward eradicating a negative strand, NAT MED, 6(7), 2000, pp. 744-745

Authors: Santos, RA Hatfield, CC Cole, NL Padilla, JA Moffat, JF Arvin, AM Ruyechan, WT Hay, J Grose, C
Citation: Ra. Santos et al., Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice, VIROLOGY, 275(2), 2000, pp. 306-317

Authors: Zerboni, L Sommer, M Ware, CF Arvin, AM
Citation: L. Zerboni et al., Varicella-zoster virus infection of a human CD4-positive T-cell line, VIROLOGY, 270(2), 2000, pp. 278-285

Authors: Abendroth, A Slobedman, B Lee, E Mellins, E Wallace, M Arvin, AM
Citation: A. Abendroth et al., Modulation of major histocompatibility class II protein expression by varicella-zoster virus, J VIROLOGY, 74(4), 2000, pp. 1900-1907

Authors: Mo, CJ Schneeberger, EE Arvin, AM
Citation: Cj. Mo et al., Glycoprotein e of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells, J VIROLOGY, 74(23), 2000, pp. 11377-11387

Authors: Asanuma, H Sharp, M Maecker, HT Maino, VC Arvin, AM
Citation: H. Asanuma et al., Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression, J INFEC DIS, 181(3), 2000, pp. 859-866

Authors: Abendroth, A Slobedman, B Springer, ML Blau, HM Arvin, AM
Citation: A. Abendroth et al., Analysis of immune responses to varicella tester viral proteins induced byDNA vaccination, ANTIVIR RES, 44(3), 1999, pp. 179-192

Authors: Shetty, AK Arvin, AM Gutierrez, KM
Citation: Ak. Shetty et al., Nocardia farcinica pneumonia in chronic granulomatous disease, PEDIATRICS, 104(4), 1999, pp. 961-964

Authors: Gutierrez, KM Halpern, MSF Maldonado, Y Arvin, AM
Citation: Km. Gutierrez et al., The epidemiology of neonatal herpes simplex virus infections in Californiafrom 1985 to 1995, J INFEC DIS, 180(1), 1999, pp. 199-202

Authors: Gans, HA Maldonado, Y Yasukawa, LL Beeler, J Audet, S Rinki, MM DeHovitz, R Arvin, AM
Citation: Ha. Gans et al., IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants, J IMMUNOL, 162(9), 1999, pp. 5569-5575

Authors: Jenkins, DE Yasukawa, LL Bergen, R Benike, C Engleman, EG Arvin, AM
Citation: De. Jenkins et al., Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination, J IMMUNOL, 162(1), 1999, pp. 560-567

Authors: Arvin, AM
Citation: Am. Arvin, Cell-mediated immunity against varicella-zoster virus, INFEC AGENT, 1998, pp. 265-290
Risultati: 1-25 |